March 2024 – Page 263 – Get News Story

Accbid: Revolutionizing the Marketplace for Social Media Assets and Businesses

In today’s digital age, where social media’s power and influence are undeniable, Accbid emerges as a pioneering platform, offering a secure and specialized marketplace for buying and selling premium social media assets and businesses. With its user-friendly interface and a robust built-in escrow system, Accbid has quickly become the go-to destination for entrepreneurs, influencers, and social media enthusiasts looking to enhance their online presence or diversify their digital portfolios.

Accbid stands out in the crowded marketplace by focusing exclusively on social media accounts, including YouTube, TikTok, and a wide array of other platforms that command the attention of millions worldwide. This specialization has made Accbid not just a marketplace but a community where sellers and buyers can connect, negotiate, and transact with confidence, knowing that their interests are protected by Accbid’s escrow service. This service ensures that funds are securely held until all terms of the transaction are met, providing peace of mind to both parties involved.

The platform’s commitment to security, transparency, and user satisfaction has fostered a thriving ecosystem where individuals and businesses can buy and sell social media assets with ease. From “stat” accounts known for their impressive analytics to coveted “OG” accounts with short, desirable usernames, Accbid caters to a wide range of needs and preferences, making it a one-stop shop for anyone looking to buy or sell high-quality social media properties.

Accbid’s success is built on a foundation of trust and reliability, offering an unparalleled level of service that includes detailed listings, direct communication channels between buyers and sellers, and a dispute resolution system designed to handle any issues swiftly and fairly. This approach has not only attracted a loyal user base but has also positioned Accbid as a leader in the social media asset marketplace.

For those looking to expand their digital footprint, Accbid offers a unique opportunity to acquire established social media accounts that can provide instant visibility, engagement, and growth potential. Conversely, sellers have access to a vast network of interested buyers, enabling them to monetize their digital assets efficiently and at competitive prices.

Accbid’s vision goes beyond mere transactions. It aims to empower individuals and businesses by providing them with the tools and opportunities to reach wider audiences, engage with communities, and achieve their digital aspirations. Whether you’re an influencer seeking to broaden your reach, a business looking to enhance your social media strategy, or an investor interested in the digital marketplace, Accbid offers a secure, transparent, and efficient platform to meet your needs.

As Accbid continues to grow and evolve, it remains committed to enhancing its offerings, improving user experience, and expanding its services to meet the ever-changing demands of the digital world. With a dedicated team, innovative technology, and a passion for social media, Accbid is poised to remain at the forefront of the social media asset marketplace for years to come.

Join the Accbid community today and unlock the potential of your online presence. Whether you’re looking to buy your first social media account or sell part of your digital portfolio, Accbid provides the tools, security, and support you need to succeed in the dynamic world of social media.

Discover the power of Accbid and take the first step towards elevating your digital journey in the expansive and ever-growing social media landscape.

For more information about Accbid and how it can help you achieve your social media goals, please contact below.

Media Contact
Company Name: Accbid
Contact Person: Tracy Li
Email: Send Email
Country: United States
Website: https://www.accbid.net/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Accbid: Revolutionizing the Marketplace for Social Media Assets and Businesses

AISignal Bot $AISig is Leveraging AI to Help Crypto Investors Make Informed Decisions

AISignal offers predictive analytics and strategic insights for crypto traders, aiming for informed investment choices.

AISignal applies artificial intelligence to offer predictive analytics and strategic insights to those trading in cryptocurrencies, aiming to assist investors in making more informed decisions. The company has introduced a sophisticated AI-powered tool, $AISig, that seeks to improve how traders navigate the complexities of the crypto market. By leveraging advanced algorithms and predictive modeling, AISignal offers a strategic advantage to those seeking to make informed trading choices.

AISignal is a technology company specializing in applying artificial intelligence to cryptocurrency trading. It offers tools and insights designed to support traders in making informed investment decisions. AISignal Bot is a tool suitable for all traders, novice or expert, helping them utilize it at any time of a trade. It tracks 3 different types of tokens and trades. The company educates traders to trade successfully with dynamic tools that do a multitude of things. Traders can find the lowest entry and best exit strategy. The tool can predict before Ethereum and Bitcoin runups, find tokens on revival, and catch new pairs at the lowest entry. It allows traders to access the complexity of information in a simple and straightforward manner that they can use from basics to advanced, servicing traders, callers, founders, and alpha groups.

A testament to its efficacy, AISignal has a track record of facilitating significant trading successes. Notably, it has enabled investors to achieve substantial returns.

Speaking to the media, L. Powell from AI Signal said, “The platform predictive modeling is nothing short of extraordinary, capturing staggering gains. We have ten months of backtests and historicals with all of the data and proof with 20 million points of data stored on the cloud. The platform has over 1000+ wins on its name with backtest and proof of the efficacy of validating the AI-predictive model.”

AISignal applies artificial intelligence to analyze cryptocurrency market trends and data from various sources. This in-depth analysis provides subscribers with comprehensive insights, empowering them to make well-informed trading decisions.

Leveraging integrating predictive modeling, AISignal identifies potential market movements, offering traders a proactive approach to their investment strategies. The platform also highlights promising tokens for investment based on thorough analysis and predictive models, steering subscribers toward opportunities with growth potential.

Understanding the dynamic nature of the crypto market, AISignal offers adaptable trading signals that reflect current market conditions. These signals consider factors such as market sentiment, trading volume, and fundamental analysis, providing a holistic strategy for crypto trading.

Central to AISignal’s offering is its robust data analytics capability, processing vast volumes of data to unveil market trends and anomalies. This comprehensive market understanding aids traders in navigating the crypto landscape more effectively.

AISignal invites traders to improve their approach to cryptocurrency trading through AI-driven insights. Through AISignal, traders can refine their strategies, make informed decisions, and engage with a supportive network of individuals keen on informed cryptocurrency trading. Subscribers to AISignal receive early alerts and expert strategies and join its telegram community of cryptocurrency enthusiasts dedicated to informed trading.

For updates, follow AISignal on Twitter: https://twitter.com/AiSignalBot

Website: https://aisignalbot.xyz/

$AISig Contract Address: 0x508b27902c6c14972a10a4e413b9cfa449e9cedb

Dextools: https://www.dextools.io/app/en/ether/pair-explorer/0x52a1b838c46bfa966201ece3ce6fb859ce645370?t=1709563557323

Uniswap: https://v2.info.uniswap.org/pair/0x52a1b838c46bfa966201ece3ce6fb859ce645370

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: AISignal
Contact Person: L. Powell
Email: Send Email
Country: United States
Website: Aisignalbot.xyz

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AISignal Bot $AISig is Leveraging AI to Help Crypto Investors Make Informed Decisions

HandyHubb is Making Waves Globally by Revolutionizing the Way Consumers and Businesses Connect

HandyHubb has emerged as a unique collaborative digital platform, facilitating consumer-business interactions across the globe. Opting for an innovative approach, Handy Hub has carved a niche for itself with its creative strategy to foster a culture of collaboration and empowerment among digital content creators, artists, freelancers, and businesses.

Since its inception in February 2017, HandyHubb has been committed to bridging the gap between consumers and businesses, especially for small to medium enterprises. Throughout their journey, the company’s core principles revolved around providing equal opportunities to all industries, irrespective of their size or financial capabilities.

HandyHubb understands that small businesses do not get enough exposure as compared to big corporations that dominate the market with hefty marketing budgets. The company has committed itself to amplifying the voices of local businesses, aiming to encourage consumers to invest more in their communities supporting these small businesses.

One shining example of the impact of community support is the influencer Keith Lee, who has championed local food communities, showcasing the power of small but consistent movements in driving change and prosperity.

HandyHubb’s real success has been the thriving community of creators and artists it has created, where individuals from diverse backgrounds join hands to shape a new era of entrepreneurship. The company has streamlined the process of identifying expert businesses and capable freelancers, ensuring that all customers connect with the ideal resources. On the other hand, HandyHubb provides a level playing field, equal opportunities, and exposure for everybody.

The team at HandyHubb consists of experienced professionals dedicated to providing a seamless experience for every user. Individuals can get started on the platform within a few minutes and boost their revenue while creating additional income streams.

With thousands of successful job matches and a rapidly expanding network of professional service providers, the company aims to help users develop meaningful connections, fueling growth and success. The platform’s forum is a dynamic space where ideas flourish, insights are shared, and collaborations are made, adding to the community’s vibrancy.

HandyHubb is a collaborative movement to guide businesses and individuals looking to gain exposure and opportunities in the competitive digital business landscape. HandyHubb calls upon consumers to support local businesses, contributing to the community.

Join HandyHubb today and be part of a transformative journey where connections empower communities and businesses to thrive. For more information, visit https://handyhubb.com/.

About HandyHubb:

Founded in 2017, HandyHubb is a collaborative digital platform connecting customers and businesses worldwide. The company has committed to extend support to businesses of all sizes and backgrounds, offering equal exposure and opportunities. With its diverse community, user-friendly interface, and dedicated team of expert individuals, HandyHubb has revolutionized the digital business landscape.

For updates, follow HandyHubb on social media:

LinkedIn: https://www.linkedin.com/company/handyhubb

Facebook: https://www.facebook.com/HHServiceMarket

Instagram: https://www.instagram.com/handyhubb

Media Contact
Company Name: HandyHubb
Contact Person: Support
Email: Send Email
City: Atlanta
State: Georgia
Country: United States
Website: www.Handyhubb.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: HandyHubb is Making Waves Globally by Revolutionizing the Way Consumers and Businesses Connect

The Respiratory Syncytial Virus Market Size in the 7MM was observed to be ~USD 1,200 million in 2022

The Respiratory Syncytial Virus market report provides current treatment practices, Respiratory Syncytial Virus emerging drugs, market share of individual therapies, and current and forecasted Respiratory Syncytial Virus market size from 2019 to 2032, segmented by seven major markets. The report also covers current Respiratory Syncytial Virus treatment practices/algorithms and Respiratory Syncytial Virus unmet needs to curate the best of the opportunities and assess the underlying potential of the market.

Key Takeaways from the Respiratory Syncytial Virus Market Research Report

The Respiratory Syncytial Virus market is expected to grow due to factors like increase in the patient pool and expected entry of emerging therapies.
In 2022, the total incident cases of Respiratory Syncytial Virus in the 7MM were ~8,495,000, and these cases are anticipated to increase during the study period.
Total incident cases of Respiratory Syncytial Virus were highest in those below 5 years, followed by 65 years and above, and the least number of cases were found in the 5 to 64 years age group.
The leading Respiratory Syncytial Virus Companies working in the market include Bavarian Nordic, GlaxoSmithKline, Janssen, Sanofi, AstraZeneca, Moderna, ReViral, Pfizer, and others.
Promising Respiratory Syncytial Virus Pipeline Therapies include Nirsevimab, RSVpreF, RSVPreF3 Vaccine, MVA-BN-RSV Vaccine, Ad26.RSV.preF, mRNA-1345, and others.

Discover which therapies are expected to grab the major respiratory syncytial virus market share @ Respiratory Syncytial Virus Market Report

Respiratory Syncytial Virus Overview

Respiratory syncytial virus (RSV) is a common respiratory virus that infects the nose, throat, lungs, and breathing passages. RSV belongs to the genus Orthopneumo virus within the family Pneumoviridae and order Mononegavirales. Members of this genus include human RSV, bovine RSV, and murine pneumonia virus. Two major antigenic subtypes of human RSV (A and B) are determined mainly by antigenic drift and duplications in RSV-G sequences but accompanied by genome-wide sequence divergence, including within RSV-F.

Respiratory Syncytial Virus Epidemiology Segmentation in the 7MM

Total Respiratory syncytial virus Incident Cases
Respiratory syncytial virus Age-specific Incident Cases

Download the report to understand which factors are driving respiratory syncytial virus epidemiology trends @ Respiratory Syncytial Virus Epidemiological Insights

Respiratory Syncytial Virus Treatment Market

Respiratory Syncytial Virus treatment is currently limited to supportive care and prophylactic antibody use. It may includehydration, supplemental oxygen, suctioning of airways, and mechanical ventilation when needed.

Bronchodilators such as albuterol have long been used and studied in RSV bronchiolitis. Unfortunately, there is noclear consensus as to their effectiveness. Although extensive research has gone into studying the effect ofbronchodilators in young infants and children, very limited studies or recommendations are available for adultpatients with RSV infection.

Because adults with RSV lower respiratory infections often have co-infections andmultiple comorbidities, it is much harder to develop a guideline that applies to such a heterogeneous population.Nebulized 3% saline solution has also been studied as a treatment for RSV bronchiolitis. Although there may be a rolefor nebulized hypertonic saline in the inpatient setting, its acute use in the ED appeared to be limited in the currentstudies. In the case of corticosteroids, there was no statistically significant benefit on hospital stay or clinicaloutcomes with the use of corticosteroids compared with placebo.

Respiratory Syncytial Virus Drugs Uptake

Nirsevimab is an immunization that provides direct prophylactic RSV protection to all infants via an antibody to help prevent LRTI caused by RSV. Monoclonal antibodies do not require the activation of the immune system to help offer rapid and direct protection against disease. With nirsevimab, the goal is to provide rapid and direct protection to the infant through a single immunization. It is the first potential immunization to show protection against RSV in infants in a Phase III trial. Currently, the drug is being studied in Phase III. Regulatory submissions have begun in the first half of 2022. Recently in September 2022, CHMP recommended approval of BEYFORTUS (nirsevimab) for the prevention of RSV disease in infants in Europe. The company plans US submission by the second half of 2022.

Pfizer’s investigational RSV vaccine candidate, RSVpreF, builds on foundational basic science discoveries, including those made at the National Institutes of Health (NIH), which detailed the crystal structure of prefusion F, a key form of the viral fusion protein (F) that RSV uses to attack human cells. The NIH research showed that antibodies specific to the prefusion form were highly effective at blocking virus infection, suggesting a prefusion F-based vaccine may confer optimal protection against RSV. After this important discovery, Pfizer tested numerous versions of the viral protein and identified those that elicited a strong antiviral immune response in preclinical evaluation. The vaccine candidate comprises two preF proteins selected to optimize protection against RSV A and B. Currently, the company is investigating this vaccine in many Phase III clinical trials.

RSVpreF 3 contains a recombinant subunit pre-fusion RSV antigen combined with GSK’s proprietary AS01 adjuvant, which is also used in the company’s shingles vaccine. The antigen plus adjuvant combination may help overcome the natural age-related decline in immunity that contributes to the challenge of protecting older adults from RSV disease.

To know more about respiratory syncytial virus guidelines, visit @ Respiratory Syncytial Virus Treatment Market

Respiratory Syncytial Virus Market Dynamics

The respiratory syncytial virus market is expected to grow due to factors like increase in the patient pool and expected entry of emerging therapies. While no RSV vaccine is currently available; however, many promising vaccine candidates are in clinical trials, which will be in the respiratory syncytial virus market soon. A safe and effective vaccine could save many lives and reduce hospitalizations significantly.

Respiratory Syncytial Virus Pipeline Therapies and Key Companies

MVA-BN-RSV Vaccine: Bavarian Nordic
RSVpreF (PF-06928316): Pfizer
RSVPreF3 (GSK3844766A) Vaccine: GlaxoSmithKline
VAC 18193 (Ad26.RSV.preF): Janssen
MEDI8897 (nirsevimab): Sanofi/AstraZeneca
mRNA-1345: Moderna
RV521/PF-07923568 (Sisunatovir): ReViral/Pfizer

Learn more about the FDA-approved respiratory syncytial virus drugs @ Drugs for Respiratory Syncytial Virus Treatment

Scope of the Respiratory Syncytial Virus Market Research Report

Coverage- 7MM
Study Period- 2019-2032
Respiratory Syncytial Virus Companies- Bavarian Nordic, GlaxoSmithKline, Janssen, Sanofi, AstraZeneca, Moderna, ReViral, Pfizer, and others.
Respiratory Syncytial Virus Pipeline Therapies- Nirsevimab, RSVpreF, RSVPreF3 Vaccine, MVA-BN-RSV Vaccine, Ad26.RSV.preF, mRNA-1345, and others.
Respiratory Syncytial Virus Market Dynamics: Respiratory Syncytial Virus Market Drivers and Barriers
Respiratory Syncytial Virus Market Access and Reimbursement, Unmet Needs

Discover more about respiratory syncytial virus drugs in development @ Respiratory Syncytial Virus Clinical Trials

Table of Content

1. Key Insights

2. Report Introduction

3. Respiratory Syncytial Virus (RSV) Market Overview at a Glance

4. Executive Summary of Respiratory Syncytial Virus (RSV)

5. Key Events

6. Disease Background and Overview

7. Treatment and Management

8. Methodology

9. Epidemiology and Patient Population

10. Patient Journey

11. Marketed Products

12. Emerging Therapies

13. Respiratory Syncytial Virus (RSV) Seven Major Market Analysis

14. Market Access and Reimbursement

15. RSV Reimbursement

16. KOL Views

17. Unmet Needs

18. SWOT Analysis

19. Appendix

20. DelveInsight Capabilities

21. Disclaimer

22. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Respiratory Syncytial Virus Market Size in the 7MM was observed to be ~USD 1,200 million in 2022

Ascites Market Size is expected to witness a major change in the study period 2019-2032, estimates DelveInsight

The Ascites market report provides current treatment practices, emerging drugs, Ascites market share of the individual therapies, and current and forecasted Ascites market size from 2019 to 2032, segmented by seven major markets. The report also covers current Ascites treatment market practices/algorithms and Ascites unmet needs to curate the best of the opportunities and assess the underlying potential of the market.

Key Takeaways from the Ascites Market Report

According to DelveInsight’s analysis, the market size for ascites across the 7MM is expected to grow with a significant CAGR by 2032.
In 2020, the total cases of Ascites due to cirrhosis in the 7MM were ~240,700. Malignant Ascites cases are calculated from ovarian cancer, stomach cancer, breast cancer, and colorectal cancer. In 2020, the number of cases of Ascites from these cancers was ~8,500; ~3,500; ~12,650; and ~10,300, respectively, in the US.
The leading Ascites companies working in the market including Ocelot Bio, Inc., PharmaIN, Grifols Therapeutics LLC, and others.
Ascites Pipeline Therapies for treatment include OCE-205, PHIN-214 Subcutaneous injection, Albutein 20% Injectable Solution, and others.

Discover which therapies are expected to grab the ascites market share @ Ascites Market Research Report

Ascites Overview

Ascites is characterized by an abnormal accumulation of fluid within the peritoneal cavity, leading to the collection of fluid in the abdominal spaces. When ascites becomes severe, it can cause discomfort and hinder the patient’s ability to move comfortably. Additionally, it has the potential to pave the way for abdominal infections and may result in the movement of fluid into the chest, enveloping the lungs. This condition poses challenges to everyday activities such as eating, drinking, and mobility, and it can also impede normal breathing.

Ascites Epidemiology Segmentation

Number of Ascites Cases due to Cirrhosis
Number of Ascites Cases by Malignancies
Severity-specific Cases of Ascites due to Cirrhosis

Download the report to understand which factors are driving ascites epidemiology trends @ Ascites Epidemiological Insights

Ascites Treatment Market

The management of ascites resulting from cirrhosis involves various approaches, including the use of diuretics, paracentesis, the placement of a transjugular intrahepatic portosystemic shunt (TIPS), and addressing complications such as spontaneous bacterial peritonitis (SBP). For mild and moderate cirrhotic ascites, treatment encompasses dietary sodium restriction, addressing the underlying condition, fluid restriction, diuretic use, and therapeutic paracentesis. In cases of refractory ascites associated with liver cirrhosis, the strategies involve optimizing medical care, performing serial large volume paracenteses, considering TIPS, peritoneovenous shunt, and exploring the option of liver transplantation.

Learn more about the FDA-approved drugs for ascites @ Drugs for Ascites Treatment

Key Ascites Therapies and Companies

BIV201: BioVie
OCE-205: Ocelot Bio

Ascites Market Dynamics

The ascites market dynamics are anticipated to change in the coming years. The rise in the patient population with underlying conditions such as liver cirrhosis, alcoholism, kidney or heart failure, malignancy, etc., may contribute to an increase in the incidence of ascites. The growing healthcare activities and campaigns emphasizing the importance of addressing ascites are bolstering the market. The Serum-Ascites Albumin Gradient plays a crucial role in accurately differentiating ascites fluid, achieving a 90% accuracy rate, and successfully identifying the underlying conditions.

To know more about ascites clinical trials, visit @ Ascites Drugs Market

Scope of the Ascites Market Research Report

Coverage- 7MM
Ascites Companies- Ocelot Bio, Inc., PharmaIN, Grifols Therapeutics LLC, and others.
Ascites Pipeline Therapies OCE-205, PHIN-214 Subcutaneous injection, Albutein 20% Injectable Solution, and others.
Ascites Market Dynamics: Ascites Market Drivers and Barriers
Ascites Market Access and Reimbursement, Unmet Needs, Future Perspectives

Discover more about ascites drugs in development @ Ascites Clinical Trials

Table of Content

1. Key Insights

2. Executive Summary of Ascites

3. Competitive Intelligence Analysis for Ascites

4. Ascites: Market Overview at a Glance

5. Ascites: Disease Background and Overview

6. Patient Journey

7. Ascites Epidemiology and Patient Population

8. Ascites Treatment Algorithm, Current Treatment, and Medical Practices

9. Ascites Unmet Needs

10. Key Endpoints of Ascites Treatment

11. Ascites Marketed Products

12. Ascites Emerging Therapies

13. Ascites: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Ascites Market Outlook

16. Ascites Market Access and Reimbursement Overview

17. Ascites KOL Views

18. Ascites Market Drivers

19. Ascites Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ascites Market Size is expected to witness a major change in the study period 2019-2032, estimates DelveInsight

Obstructive Sleep Apnea Market Size in the 7MM is approximately USD 400 million in 2022

DelveInsight’s Obstructive Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, obstructive sleep apnea emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Takeaways from the Obstructive Sleep Apnea Market Report

As per DelveInsight analysis, the obstructive sleep apnea market size in the 7MM was approximately USD 408 million in 2022.
According to the assessment done by DelveInsight, the estimated total prevalent obstructive sleep apnea cases in the 7MM were approximately 24 million in 2022.
Globally, leading obstructive sleep apnea companies such as Apnimed, Eli Lilly and Company, Therapix Biosciences, Bioprojet Pharma, Axsome Therapeutics/ Jazz Pharmaceuticals and others are developing novel obstructive sleep apnea drugs that can be available in the obstructive sleep apnea market in the coming years.
The promising obstructive sleep apnea therapies in the pipeline include AD109, Tirzepatide, and others.
In January 2023, Aculys Pharma initiated a Phase III trial of Pitolisant treating patients with EDS associated with OSA in Japan.

Discover which therapies are expected to grab the major obstructive sleep apnea market share @ Obstructive Sleep Apnea Market Research Report

Obstructive Sleep Apnea Overview

Obstructive sleep apnea, also known as obstructive sleep apnea-hypopnea, is a sleeping disorder that causes the airflow to stop or drastically decrease while breathing is attempted. It is the most common type of sleep-disordered breathing and is characterized by recurring bouts of upper airway collapse as a person sleeps. Common obstructive sleep apnea symptoms include inexplicable daytime tiredness, restless sleep, and loud snoring. Morning headaches; sleeplessness; difficulty concentrating; and mood changes such as impatience, anxiety, melancholy, and others are less prevalent obstructive sleep apnea symptoms.

Obstructive Sleep Apnea Epidemiology Segmentation

Total Obstructive Sleep Apnea Diagnosed Prevalent Cases
Obstructive Sleep Apnea Gender-specific Diagnosed Prevalent Cases
Obstructive Sleep Apnea Age-specific Diagnosed Prevalent Cases
Obstructive Sleep Apnea Severity-specific Diagnosed Cases

Download the report to understand which factors are driving obstructive sleep apnea epidemiology trends @ Obstructive Sleep Apnea Epidemiological Insights

Obstructive Sleep Apnea Treatment Market

Obstructive sleep apnea is often treated with weight loss and exercise, CPAP therapy (the first line of obstructive sleep apnea treatment), bilevel positive airway pressure (BPAP) equipment (if CPAP therapy is ineffective), and surgery. EDS, the most usually related indication, can be treated with PROVIGIL/MODIODAL (modafinil), NUVIGIL (armodafinil), SUNOSI (solriamfetol), Pitolisant, and certain other off-label medications. PROVIGIL (modafinil), which Cephalon introduced in 1999, is used to treat excessive drowsiness caused by narcolepsy, obstructive sleep apnea, and shift work disorder. Provigil is approved for the treatment of EDS associated with narcolepsy in over 30 countries outside the United States, including France, the United Kingdom, Ireland, Italy, and Germany, under several trade names.

To know more about obstructive sleep apnea treatment guidelines, visit @ Obstructive Sleep Apnea Treatment Landscape

Obstructive Sleep Apnea Therapies and Key Companies

AD109: Apnimed
Tirzepatide: Eli Lilly and Company
AD113: Apnimed
SUNOSI (Solriamfetol): Axsome Therapeutics/Jazz Pharmaceuticals
OZAWADE (Pitolisant): Bioprojet Pharma

Learn more about the FDA-approved drugs for obstructive sleep apnea @ Drugs for Obstructive Sleep Apnea Treatment

Obstructive Sleep Apnea Market Dynamics

The dynamics of the obstructive sleep apnea market are expected to change in the coming years. The tremendous growth of the sleep apnea diagnosis market over the last decade can be linked to the constant advancement of sleep apnea therapy utilization. Moreover, obstructive sleep apnea is poorly understood; implementing programs such as “sleep awareness week” by various organizations and government agencies might boost the diagnosis rate and obstructive sleep apnea treatment.

Obstructive Sleep Apnea Drugs Uptake

AD109, a lead product of Apnimed in Phase III, is a first-in-class, oral pharmaceutical combination dosed once daily at bedtime, designed to treat OSA patients across a broad spectrum of disease severity. AD109 combines a selective norepinephrine reuptake inhibitor (NRI), atomoxetine, with a novel NCE selective antimuscarinic, aroxybutynin and has been granted with FTD.

Tirzepatide sponsored by Eli Lilly and Company is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. It is in Phase III development for OSA and is also being studied for adults with obesity or overweight with weight-related comorbidity, heart failure with preserved ejection fraction (HFpEF), and nonalcoholic steatohepatitis (NASH).

Scope of the Obstructive Sleep Apnea Market Report

Therapeutic Assessment: Obstructive Sleep Apnea current marketed and emerging therapies
Obstructive Sleep Apnea Market Dynamics: Attribute Analysis of Emerging Obstructive Sleep Apnea Drugs
Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Unmet Needs, KOL’s Views, Analyst’s Views, Obstructive Sleep Apnea Market Access and Reimbursement

Discover more about obstructive sleep apnea drugs in development @ Obstructive Sleep Apnea Clinical Trials

Table of Content

1. Key Insights

2. Report Introduction

3. Obstructive Sleep Apnea Market Overview at a Glance

4. Executive Summary of Obstructive Sleep Apnea

5. Epidemiology and Market Methodology

6. Key Events

7. Disease Background and Overview Obstructive Sleep Apnea

8. Epidemiology and Patient Population of Obstructive Sleep Apnea

9. Patient Journey

10. Obstructive Sleep Apnea Marketed drugs

11. Obstructive Sleep Apnea Emerging Drugs

12. Obstructive Sleep Apnea: Seven Major Market Analysis

13. Obstructive Sleep Apnea Unmet Needs

14. Obstructive Sleep Apnea SWOT Analysis

15. Key Opinion Leaders’ Views

16. Obstructive Sleep Apnea Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Obstructive Sleep Apnea Market Size in the 7MM is approximately USD 400 million in 2022

Cardiac Safety Services Market Growth, Top Key Players, Share, Size, and Projections up to 2027

“Cardiac Safety Services Market in terms of revenue was estimated to be worth $739 million in 2023 and is poised to reach $1,282 million by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new report by MarketsandMarkets™”

In the near future, the cardiac safety services industry is poised for significant growth and innovation. As pharmaceutical research continues to advance, the demand for robust cardiac safety assessments throughout drug development pipelines will remain crucial.

Cardiac Safety Services Market in terms of revenue was estimated to be worth $739 million in 2023 and is poised to reach $1,282 million by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is driven by rising incidence of cardiovascular diseases, large number of cardiac issue related clinical trials. Additionally, the increasing outsourcing of cardiac safety services leading to expanded adoption of cardiac safety services.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174488627

The integrated services segment accounted for the largest share, by type in the cardiac safety services market in 2022.

By type, the cardiac safety services market has been further categorized as integrated services and standalone services. The integrated services segment held the largest share of the global cardiac safety services market in 2022. This can be attributed to benefits associated with integrated services. Integrated services offer benefits such as comprehensive data integration and improved data quality. Additionally, these services help enhance and expedite clinical trials in the pharmaceutical and biopharmaceutical development cycle. These advantages make integrated services as preferable option against standalone cardiac safety services.

The ECG/ Holter measurement services segment accounted for the largest share of the service type segment in the cardiac safety services market in 2022.

Based on service type, the global cardiac safety services market has been segmented into ECG/Holter measurement services, blood pressure measurement services, cardiovascular imaging services, thorough QT studies, and other cardiac safety services. The ECG/ Holter measurement services segment held the largest market share in 2022. The large share of this segment can be attributed to the low cost of ECG/Holter services and rigorous regulations for drug safety, increasing research & development activities to develop effective and innovative drugs.

The North America region catered the largest share of the cardiac safety services market in 2022.

The cardiac safety services market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to large pharmaceutical & biopharmaceutical industry in the region, the rising R&D expenditure, stringent regulations, and the presence of major providers of cardiac safety services in the US and Canada. Additionally, growth of the North American cardiac safety services market is driven by significant factors such as a multitude of ongoing clinical trials, the expansion of the biosimilars and generics sector, and the increasing adoption of outsourcing preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174488627

Cardiac Safety Services Market Dynamics:

Drivers:

Rising incidence of cardiovascular diseases

Restraints:

Inadequacy of cardiotoxicity testing

Opportunities:

Emergence of new methods to curb cardiotoxicity

Challenge:

High cost of cardiac safety evaluation services

Key Market Players:

Key players in the cardiac safety services market include Laboratory Corporation of America Holdings (US), Koninklijke Philips N.V. (Netherlands), Clario (US), Banook Group (France), IQVIA (US), Biotrial (France), Certara (US), Celerion (US), Medpace (US), Ncardia (Netherlands), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medical (China), Pharmaceutical Product Development, Inc. (US), and SGS S.A. (Switzerland).

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174488627

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cardiac-safety-services-market-174488627.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cardiac Safety Services Market Growth, Top Key Players, Share, Size, and Projections up to 2027

Blood screening market Size, Growth, Share, Opportunities, Key Products, Applications, Segments, Trends, Regional Graph and Forecast to 2028

“North America has the largest share and is continuing to dominate the blood screening market.”

The blood screening industry is poised for a transformative future as technological advancements continue to drive innovation. In the near future, we can expect a paradigm shift in the way blood screening is conducted, with the integration of cutting-edge automation, artificial intelligence, and molecular biology techniques.

Blood Screening Market in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in this market is mainly driven by the growing requirement for donated blood, the rising number of blood donations around the world, and the ever-increasing infectious diseases. However, operational barriers and the high cost of Blood screening instruments is likely to hamper the growth of blood screening market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

The Reagents & Kits segment is expected to account for the largest share in 2022.

Based on product, the blood screening market is segmented into reagents & kits, instruments, and software & services. Increase in demand and continuous use of the reagents and kits during blood transfusion processes, post blood donations is responsible for the large segment of this segment.

Nucleic Acid Test segment aimed the highest share during the forecast period

The blood screening market is segmented into nucleic acid tests (NAT), serology/immunoassay, rapid tests, western blot assays, and next-generation sequencing (NGS). In 2022, the nucleic acid test (NAT) segment accounted for the largest share of the blood screening market. From all the other technologies, NAT provides high precision, sensitivity and accuracy for blood screening and therefore, holds the largest share.

North America has the upper hand in the global Blood screening market

By regional segmentation, the blood screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America has the largest share and is continuing to dominate the blood screening market. The factors responsible for the large share of North America in this market are the increasing prevalence of infectious diseases, rising awareness in blood donations, and the growing healthcare system that is highly developed in the US and Canada.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267747042

Blood Screening Market Dynamics:

Drivers:

Increasing number of blood donations worldwide

Restraints:

Alternative technologies

Opportunities:

Emerging markets

Challenge:

High cost of blood screening technologies

Key Market Players:

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Grifols (Spain), Abbott Laboratories, Inc. (US), Bio-Rad Laboratories, Inc. (US), Danaher (Beckman Coulter, Inc.) (US), bioMérieux (France), Hologic (US), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), Siemens Healthineers (Germany), QuidelOrtho Corporation (US), Merck KGaA (Germany), Revvity (Earlier known as PerkinElmer Inc.) (US), Bio-Techne Corporation (US), GFE (Germany), Trinity Biotech (Ireland), Mindray (China), Maccura Biotechnology Co., Ltd. (China), Immucor, Inc. (US), Cellabs (Australia), Abnova Corporation (Taiwan), Enzo Biochem, Inc. (US), J. Mitra & Co. Pvt. Ltd. (India) and Tulip Diagnostics (India).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=267747042

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blood screening market Size, Growth, Share, Opportunities, Key Products, Applications, Segments, Trends, Regional Graph and Forecast to 2028

Automotive Ethernet Market worth USD 5.5 billion by 2028, at a CAGR of 19.7%

“Automotive Ethernet Market”

Automotive Ethernet Market by Type (Automotive Ethernet Network, Automotive Ethernet Testing), Component Type (Hardware, Software, Services), Bandwidth, Application, Vehicle Type (Passenger Cars & Commercial Vehicles) & Region – Global Forecast to 2028

The global Automotive ethernet market size is projected to grow from USD 2.2 billion in 2023 to USD 5.5 billion by 2028, at a CAGR of 19.7%. The increasing demand for faster in-vehicle networking is expected to increase the demand for automotive ethernet. Additionally, continuous innovation in connected car features will boost the demand for automotive ethernet.

Network segment is expected to have largest share in the global automotive ethernet market

The network segment is expected to hold the largest share of the automotive ethernet market during the forecast period. The network section of automotive ethernet is undergoing tremendous growth, exceeding other areas, as the vehicle landscape evolves toward smart features, connectivity, and autonomous driving. The necessity for high-bandwidth connection for infotainment and ADAS, the cost-effectiveness and scalability of ethernet compared to older CAN bus systems, and its role in enabling crucial technologies like V2X communication are all driving this boom. Automotive ethernet product and solution providers are working closely with automakers to develop and provide efficient solutions. For instance, NXP Semiconductors announced in July 2023 that it will be working together with Mahindra and Mahindra, Ltd. (India) over connected vehicles. Automotive ethernet, with its improved data processing capabilities and futureproof architecture, serves as the foundation for next-generation cars, assuring safer, more efficient, and more sophisticated transportation experiences.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103704247

2.5/5/10 Gbps bandwidth segment is estimated to exhibit the fastest growth in global automotive ethernet market

The 2.5/5/10 Gbps bandwidth range in automotive Ethernet signifies an exponential leap in data transfer rates, facilitating ultra-high-speed communication within vehicles. This standard enables a host of highly data-intensive applications, including extremely high-definition multimedia streaming, intricate real-time sensor fusion for advanced autonomous driving systems, and the seamless integration of complex vehicle-to-vehicle (V2V) and vehicle-to-infrastructure (V2I) communication. This 2.5/5/10 Gbps bandwidths are defined by IEEE 802.3ch. PAM4 encoding, full duplex transmission, and a point-to-point topology are used by 2.5/5/10 Gbps bandwidths. These bandwidths allow the high data speeds required for autonomous driving systems. To deliver high-resolution video for image recognition, these applications demand lossless video transmission. Autonomous driving systems are linked to actuators that can assume control of the car, and there must be no interruptions in the video or other connections. Multiple companies in automotive ethernet market are providing products and solutions capable of supporting such high bandwidth. For example, Q6223 automotive ethernet switch was released by Marvell Technology, Inc. in June 2023 which houses multiple PHYs capable of 2.5 Gbps data transfer speed.

Germany to lead the automotive ethernet market in Europe

Germany is expected to be the largest market in Europe for automotive ethernet during the forecast period. Automotive Ethernet is growing rapidly in Germany, owing to the country’s position as a worldwide automotive powerhouse and its continuous dedication to technical innovation. Germany, known for engineering prowess and cutting-edge automobile manufacture, is at the forefront of driving automotive developments. The country’s automotive and technology behemoths are actively leading R&D efforts, with an emphasis on incorporating modern technologies such as driver monitoring, OTA software updates, and high-speed networking solutions into automobiles. The primary elements driving its growth in Germany include the industry’s relentless pursuit of technological advancements, government support for research and innovation, stringent safety standards that necessitate robust in-vehicle networking solutions, and a consumer base that increasingly demands vehicles with cutting-edge safety features and seamless connectivity. Germany has a significant presence of automotive ethernet product and solutions providers such as Rhode & Schwarz, Ruetz System Solutions GmbH, Infineon Technologies AG and TSN Systems GmbH. In February 2023, Rhode & Schwarz announced an investment of USD 65.2 million to develop a new research and manufacturing center in the country.

Key Players

The automotive ethernet market is dominated by global players such as Broadcom (US), Marvell (US), Microchip Technology Inc. (US), NXP Semiconductors (Netherlands), and Texas Instruments Incorporated (US), among others. These companies adopted new product development strategies, expansion, partnerships & collaborations, and mergers & acquisitions to gain traction in the market.

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=103704247

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Automotive Ethernet Market worth USD 5.5 billion by 2028, at a CAGR of 19.7%

Pipe Insulation Market Size, Growth, Opportunities, Share, Industry Analysis, Key Segments, Regional Graph and Forecast to 2027

“Browse 172 market data Tables and 62 Figures spread through 209 Pages and in-depth TOC on “Pipe Insulation Market””

Pipe Insulation Market by Material Type (Rockwool, Fiberglass, PUR & PIR foam, Elastomeric foam), Application (Industrial, Oil, District Energy Systems, Building & Construction), and Region (North America, Europe, APAC, MEA, RoW) – Global Forecast to 2027

The global pipe insulation market will grow to USD 2.6 billion by 2027, at a CAGR of 3.8% from USD 2.2 billion in 2022.Pipe insulation is composed of materials or a combination of materials, which add a protective covering to pipes and reduce the heat loss or heat gain from surfaces operating at temperatures above or below the surrounding temperatures. It prevents the formation of condensation on pipework, and thus acts as a protective barrier against moisture, which can build up inside a pipe, leading to different types of corrosion.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263389325

The key market players profiled in the report include Saint-Gobain S.A. (France), BASF S E (Germany), Johns Manville (US), Owens Corning (US), Kingspan Group PLC (UK), Rockwool A/S (Denmark), Covestro AG (Germany), Huntsman Corporation (US), Armacell (Luxembourg) and Knauf Insulation (US) and others.

Saint-Gobain S.A. is among the largest players in insulation market and is focusing on expanding the availability of its products and services in different regions. The company focuses on the field of stone wool material which provides pipe insulation for the different applications. As there is rising demand for glass wool insulation the company tend to expand its production in its ISOVER plant at France which is strengthened its market value in Europe.

In March 2022, company made an investment in a new blowing glass wool production line in its ISOVER plant in France to meet the rising demand of the French market for roof space thermal insulation solutions.

BASF SE is a highly innovative company and delivers superior-quality products to its customers in line with the accelerating demands of the market. The company’s strength lies in the core business of production and processing of chemicals. The research and development department of the company upgrades the products according to the customer’s demand time-to-time which makes it look more attractive.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=263389325

Central and Eastern Europe, including Russia, Poland, and other countries in the region, are experiencing notable growth in the pipe insulation market. This growth is primarily driven by Russia’s substantial oil production and rising demand for district heating systems. The European Energy Performance of Buildings Directive (EPBD) (2002/91/EEC) plays a key role in supporting the expansion of rockwool, a significant component in pipe insulation, across the EU.

Read Our Trending Press Release Below:

Aluminium Foam Manufacturers

Flow Chemistry Companies

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pipe Insulation Market Size, Growth, Opportunities, Share, Industry Analysis, Key Segments, Regional Graph and Forecast to 2027